NIH Director's Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)
Application budgets are not limited but must be commensurate with the scope of the proposed research.
September 03, 2026
Office of the Director (OD)
Email: Transformative_Awards@mail.nih.gov
The NIH Director's Transformative Research Award supports collaborative investigative teams or individual scientists who propose unusually bold and innovative research projects, which, if successful, would have a major impact in a broad area of relevance to the NIH. To be considered transformative, projects must have the potential to establish new or overturn fundamental scientific paradigms through novel concepts or perspectives, transform the way research is conducted through the development of novel tools or technologies, or lead to major improvements in health through the development of highly innovative diagnostic, therapeutic, or preventive strategies.
Several key features of this NOFO are designed to emphasize to applicants and peer reviewers that Transformative Research applications are very different from conventional, investigator-initiated research applications. The Transformative Research application focuses on the importance of the problem, the novelty of the hypothesis and/or the proposed methodology, and the magnitude of the potential impact rather than on preliminary data or experimental details. Reviewers will be instructed to emphasize the significance and innovation of the application in their evaluations. Applicants and reviewers should keep the goal of the Transformative Research Award initiative in mind throughout the process– to solicit and fund unusually innovative and potentially transformative research.
Applications are welcome in all research areas broadly relevant to the mission of NIH. Research may be basic, translational, or clinical. The primary requirements are that the research be highly innovative and have the potential for unusually broad impact.
NIH program staff will hold a pre-application webinar to explain the program and answer questions about the application and review process. Check the NIH Calendar of Events for more information. Questions should be sent to Transformative_Awards@mail.nih.gov. More information, FAQs, application guide, contacts for clinical trials, and webinar recording are on the Common Fund website.
The NIH Director's Transformative Research Award is part of the High-Risk, High-Reward Research program funded through the NIH Common Fund, which supports cross-cutting programs that are expected to have exceptionally high impact. All Common Fund initiatives invite investigators to develop bold, innovative, and often risky approaches to address problems that may seem intractable or to seize new opportunities that offer the potential for rapid progress.
Investigators proposing NIH-defined clinical trials may refer to the Research Methods Resources website for information about developing statistical methods and study designs.